Primary cutaneous follicle center lymphoma associated with alopecia areata

Clinical Lymphoma and Myeloma

Volumn 8, Issue 2, 2008, Pages 121-124

  Richmond, Heather M ^a,d   Lozano, Annabelle ^b   Jones, Dan ^c   Duvic, Madeleine ^c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d NONE   (United States)

Author keywords

Atypical T cells; Cutaneous T cell lymphoma; Follicular mucinosis; Imiquimod

Indexed keywords

IMIQUIMOD; RITUXIMAB; STEROID; T LYMPHOCYTE RECEPTOR;

ADULT; ALOPECIA AREATA; ARTICLE; B LYMPHOCYTE; CASE REPORT; CELL POPULATION; CUTANEOUS T CELL LYMPHOMA; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MEGADOSE; FACE; GENE REARRANGEMENT; HUMAN; LYMPHOCYTE SUBPOPULATION; MALE; MULTIPLE CYCLE TREATMENT; PRIMARY CUTANEOUS FOLLICLE CENTER LYMPHOMA; SCALP; SKIN BIOPSY; T LYMPHOCYTE;

EID: 44649124290     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2008.n.015     Document Type: Article

References (12)

1. Morgan M, Maloney D, Duvic M. Hypomagnesemia and hypocalcemia in mycosis fungoides: a retrospective case series. Leuk Lymphoma 2002; 43:1297-302.
2. Benchikhi H, Wechsler J, Rethers L, et al. Cutaneous B-cell lymphoma associated with follicular mucinosis. J Am Acad Dermatol 1995; 33:673-5.
3. Barzilai A, Trau H, David M, et al. Mycosis fungoides associated with B-cell malignancies. Br J Dermatol 2006; 155:379-86.
4. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105:3768-85.
5. Gilhar A, Kalish RS. Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev 2006; 5:64-9.
6. Hoefer HF, Chen SH, Duvic MA, et al. Alopecia, hypohidrosis, and ulcerations in a man: mycosis fungoides. Arch Dermatol 2002; 138:527-32.
7. Hanson M, Hill A, Duvic M. Bexarotene reverses alopecia in cutaneous T-cell lymphoma. Br J Dermatol 2003; 149:193-6.
8. Jackow CM, McHam J, Friss A, et al. HLA-DR5 and DQB1*03 Class II alleles are associated with cutaneous T-cell lymphoma. J Invest Dermatol 1996; 107:373-6.
9. Washington LT, Huh YO, Powers LC, et al. A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy. BMC Clin Pathol 2002; 2:5.
10. Jones D, Duvic M. The current state and future of clonality studies in mycosis fungoides. J Invest Dermatol 2003; 121:ix-x.
11. Lukowsky A, Muche JM, Sterry W, et al. Detection of expanded T cell clones in skin biopsy samples of patients with lichen sclerosus et atrophicus by T cell receptor-gamma polymerase chain reaction assays. J Invest Dermatol 2000; 115:254-9.
12. Magro C, Crowson AN, Kovatich A, et al. Pityriasis lichenoides: a clonal T-cell lymphoproliferative disorder. Hum Pathol 2002; 33:788-95.